Cogent Biosciences Stock Technical Analysis
| COGT Stock | USD 8.39 0.02 0.24% |
As of the 10th of June, Cogent Biosciences shows the Mean Deviation of 3.57, downside deviation of 4.15, and Risk Adjusted Performance of 0.0624. Cogent Biosciences technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
Cogent Biosciences Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Cogent, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to CogentCogent |
Cogent Biosciences Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 22.11 | Strong Buy | 11 | Odds |
Most Cogent analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Cogent stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Cogent Biosciences, talking to its executives and customers, or listening to Cogent conference calls.
Cogent Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Cogent Biosciences Technical Analysis
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Cogent Biosciences volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Cogent Biosciences Trend Analysis
Use this graph to draw trend lines for Cogent Biosciences. You can use it to identify possible trend reversals for Cogent Biosciences as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Cogent Biosciences price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Cogent Biosciences Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Cogent Biosciences applied against its price change over selected period. The best fit line has a slop of 0.03 , which means Cogent Biosciences will continue generating value for investors. It has 122 observation points and a regression sum of squares at 44.48, which is the sum of squared deviations for the predicted Cogent Biosciences price change compared to its average price change.About Cogent Biosciences Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Cogent Biosciences on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Cogent Biosciences based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Cogent Biosciences price pattern first instead of the macroeconomic environment surrounding Cogent Biosciences. By analyzing Cogent Biosciences's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Cogent Biosciences's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Cogent Biosciences specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2021 | 2022 | 2023 | 2024 (projected) | Current Ratio | 13.04 | 9.87 | 7.09 | 6.68 | Net Debt To EBITDA | 2.87 | 0.81 | 0.17 | 0.16 |
Cogent Biosciences June 10, 2024 Technical Indicators
Most technical analysis of Cogent help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Cogent from various momentum indicators to cycle indicators. When you analyze Cogent charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0624 | |||
| Market Risk Adjusted Performance | (0.32) | |||
| Mean Deviation | 3.57 | |||
| Semi Deviation | 3.86 | |||
| Downside Deviation | 4.15 | |||
| Coefficient Of Variation | 1147.69 | |||
| Standard Deviation | 4.63 | |||
| Variance | 21.39 | |||
| Information Ratio | 0.0847 | |||
| Jensen Alpha | 0.3944 | |||
| Total Risk Alpha | 0.3845 | |||
| Sortino Ratio | 0.0943 | |||
| Treynor Ratio | (0.33) | |||
| Maximum Drawdown | 19.97 | |||
| Value At Risk | (6.72) | |||
| Potential Upside | 9.75 | |||
| Downside Variance | 17.25 | |||
| Semi Variance | 14.87 | |||
| Expected Short fall | (4.07) | |||
| Skewness | 0.3396 | |||
| Kurtosis | 0.1072 |
Additional Tools for Cogent Stock Analysis
When running Cogent Biosciences' price analysis, check to measure Cogent Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cogent Biosciences is operating at the current time. Most of Cogent Biosciences' value examination focuses on studying past and present price action to predict the probability of Cogent Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cogent Biosciences' price. Additionally, you may evaluate how the addition of Cogent Biosciences to your portfolios can decrease your overall portfolio volatility.